This Quarterly Report on Form 10-Q (this "Report") contains forward-looking
statements. When used anywhere in this Report, the words "expect," "believe,"
"anticipate," "estimate," "intend," "plan" and similar expressions are intended
to identify forward-looking statements. These statements relate to future events
or our future financial or operational performance and involve known and unknown
risks, uncertainties and other factors that could cause our actual results,
levels of activity, performance or achievements to differ materially from those
expressed or implied by these forward-looking statements. These statements
include, but are not limited to, the effect of the COVID-19 pandemic on our
business, financial condition and results of operations. We disclaim any
undertaking to publicly update or revise any forward-looking statements
contained herein to reflect any change in our expectations with regard thereto
or any change in events, conditions or circumstances on which any such statement
is based. These statements reflect our current views with respect to future
events and are based on assumptions subject to risks and uncertainties. Such
risks and uncertainties include those related to our ability to sell our
products.

  The following discussion and analysis of our financial condition and results
of operations should be read in conjunction with our consolidated financial
statements and related notes included in our Annual Report on Form 10-K/A for
the fiscal year ended August 29, 2020 ("Annual Report") and our unaudited
condensed consolidated financial statements and the related notes appearing
elsewhere in this Report. In addition to historical information, the following
discussion contains forward-looking statements, including but not limited to,
statements regarding the Company's expectation for future performance, liquidity
and capital resources that involve risks, uncertainties and assumptions that
could cause actual results to differ materially from the Company's expectations.
The Company's actual results may differ materially from those contained in or
implied by any forward-looking statements. Factors that could cause such
differences include those identified in Item 1A. "Risk Factors" of our Annual
Report. The Company assumes no obligation to update any of these forward-looking
statements.

Unless the context requires otherwise in this Report, the terms "we," "us," "our," the "Company" and "Simply Good Foods" refer to The Simply Good Foods Company and its subsidiaries.

Overview

The Simply Good Foods Company is a consumer-packaged food and beverage company
that aims to lead the nutritious snacking movement with trusted brands that
offer a variety of convenient, innovative, great-tasting, better-for-you snacks
and meal replacements. Our nutritious snacking platform consists of the
following core brands that specialize in providing products for consumers that
follow certain nutritional philosophies, dietary approaches and/or
health-and-wellness trends: Atkins® for those following a low-carb lifestyle;
and Quest® for consumers seeking to partner with a brand that makes the foods
they crave work for them, not against them, through a variety of protein-rich
foods and beverages that also limit sugars and simple carbs. We distribute our
products in major retail channels, primarily in North America, including
grocery, club and mass merchandise, as well as through e-commerce, convenience,
specialty and other channels. Our portfolio of nutritious snacking brands gives
us a strong platform with which to introduce new products, expand distribution,
and attract new consumers to our products. Our platform also positions us to
continue to selectively pursue acquisition opportunities of brands in the
nutritious snacking category.

  To that end, in November 2019, we completed the acquisition of Quest
Nutrition, LLC ("Quest"), a healthy lifestyle food company, for a cash purchase
price of approximately $1.0 billion (subject to customary adjustments) (the
"Acquisition of Quest"). For more information, please see "Liquidity and Capital
Resources-Acquisition of Quest."

Effects of COVID-19



  In December 2019, a novel coronavirus disease, or COVID-19, was reported and
in January 2020, the World Health Organization ("WHO") declared it a Public
Health Emergency of International Concern. On February 28, 2020, the WHO raised
its assessment of the COVID-19 threat from high to very high at a global level
due to the continued increase in the number of cases and affected countries, and
on March 11, 2020, the WHO characterized COVID-19 as a pandemic. On March 27,
2020, the Coronavirus Aid, Relief, and Economic Security ("CARES") Act was
signed into law. The CARES Act provided a substantial stimulus and assistance
package intended to address the effect of the COVID-19 pandemic, including tax
relief and government loans, grants and investments. Additionally, various
federal, state and local government-imposed movement restrictions and
initiatives have been implemented to reduce the global transmission of COVID-19,
including reduced or eliminated food services, the closure of retailing
establishments, the promotion of social distancing and the adoption of remote
working policies.

  Beginning in the third quarter of 2020, we actively engaged with the various
elements of our value chain, including our customers, contract manufacturers,
and logistics and transportation providers, to meet demand for our products and
to remain informed of any challenges within our value chain. Given the
unpredictable nature of the COVID-19 pandemic and the initial surge in
consumption, we increased finished goods inventory of some of our key products.
In the fourth quarter of 2020 and continuing into the second quarter of 2021,
consumer consumption habits became more steady and inventory levels normalized.
Based on information available to us as of the
                                       24
--------------------------------------------------------------------------------

date of this Report, we believe we will be able to deliver our products to meet
customer orders on a timely basis, and therefore, we expect our products will
continue to be available for purchase to meet consumer meal replacement and
snacking needs for the foreseeable future. We continue to monitor customer and
consumer demand, and intend to adapt our plans as needed to continue to drive
our business and meet our obligations during the evolving COVID-19 situation.

  Our consolidated results of operations for the thirteen and thirty-nine weeks
ended May 29, 2021 continued to be affected by changes in consumer shopping and
consumption behavior due to COVID-19. However, for the thirteen and thirty-nine
weeks ended May 29, 2021, our business improved, driven by increasing consumer
mobility and improving shopper traffic in brick and mortar retailers versus the
prior year period that was pressured by COVID-19 movement restrictions. We
believe there is a high correlation of consumer mobility to the consumption of
our products. As shopper traffic within brick and mortar retailers improves,
particularly in the mass and convenience store channels, our business,
particularly bars, performs well. There is still uncertainty related to the
duration of reduced consumer mobility and when shopping trips will fully return
to pre-pandemic levels. While our Quest brand has outperformed its portion of
the nutritious snacking segment, the performance of our Atkins brand, which is
part of the weight management portion of the market, has improved at a slower
rate. However, the Atkin's performance for the thirteen weeks ended May 29, 2021
has improved sequentially, primarily due to increasing consumer mobility and
improving shopper traffic in brick and mortar retailers.

  We remain uncertain of the ultimate effect COVID-19 could have on our business
notwithstanding the distribution of several U.S. government approved vaccines
and the easing of movement restrictions. This uncertainty stems from the
potential for, among other things, (i) the possibility for mutations of COVID-19
to result in increased rates of reported cases for which currently approved
vaccines are not effective, (ii) unexpected supply chain disruptions, (iii)
changes to customer operations, (iv) reversal in recently improving consumer
purchasing and consumption behavior, and (v) the closure of customer
establishments.

Restructuring and Related Charges



  In May 2020, we announced certain restructuring activities in conjunction with
the implementation of our future-state organization design, which created a
fully integrated organization with our completed Acquisition of Quest. The new
organization design became effective on August 31, 2020. These restructuring
plans primarily include workforce reductions, changes in management structure,
and the relocation of business activities from one location to another.

  For the thirteen and thirty-nine weeks ended May 29, 2021, we incurred a total
of $0.2 million and $4.0 million in restructuring and restructuring-related
costs, respectively, which have been included within General and administrative
on the Condensed Consolidated Statements of Operations and Comprehensive Income.
As of May 29, 2021, we have incurred aggregate restructuring and
restructuring-related costs of $9.5 million since May 2020. Overall, we expect
to incur a total of approximately $9.9 million in restructuring and
restructuring-related costs, which are to be paid throughout fiscal 2021 and the
first quarter of fiscal 2022. Refer to Note 14, Restructuring and Related
Charges, of our Notes to Unaudited Condensed Consolidated Financial Statements
in this Report for additional information regarding restructuring activities.

SimplyProtein Sale



  Effective September 24, 2020, we sold the assets exclusively related to our
SimplyProtein® brand of products for approximately $8.8 million of
consideration, including cash of $5.8 million and a note receivable for
$3.0 million, to a newly formed entity led by the Company's former
Canadian-based management team who had been responsible for this brand prior to
the sale transaction (the "SimplyProtein Sale"). In addition to purchasing these
assets, the buyer assumed certain liabilities related to the SimplyProtein®
brand's business. There was no gain or loss recognized as a result of the
SimplyProtein Sale. The transaction enables our management to focus its full
time and our resources on our core Atkins® and Quest® branded businesses and
other strategic initiatives.

Supply Chain Costs



  As we expect higher raw material and freight costs starting in the fiscal
fourth quarter of 2021 and in fiscal year 2022, in June 2021 management notified
our customers of our plans to institute a price increase effective in September
2021, the first month of our fiscal year 2022. Management believes the price
increase will enable us to continue to invest in initiatives that drive growth.
                                       25
--------------------------------------------------------------------------------

Key Financial Definitions

Net sales. Net sales consist primarily of product sales less the cost of promotional activities, slotting fees and other sales credits and adjustments, including product returns.



  Cost of goods sold. Cost of goods sold consists primarily of the costs we pay
to our contract manufacturing partners to produce the products sold. These costs
include the purchase of raw ingredients, packaging, shipping and handling,
warehousing, depreciation of warehouse equipment, and a tolling charge for the
contract manufacturer. Cost of goods sold includes products provided at no
charge as part of promotions and the non-food materials provided with customer
orders.

Operating expenses. Operating expenses consist primarily of selling and marketing, general and administrative, depreciation and amortization, and business transaction costs. The following is a brief description of the components of operating expenses:



•Selling and marketing. Selling and marketing expenses comprise broker
commissions, customer marketing, media and other marketing costs.
•General and administrative. General and administrative expenses comprise
expenses associated with corporate and administrative functions that support our
business, including employee salaries, professional services, integration costs,
restructuring costs, insurance and other general corporate expenses.
•Depreciation and amortization. Depreciation and amortization costs consist of
costs associated with the depreciation of fixed assets and capitalized leasehold
improvements and amortization of intangible assets.
•Business transaction costs. Business transaction costs comprise legal, due
diligence, consulting and accounting firm expenses associated with the process
of actively pursuing potential and completed business combinations, including
the Acquisition of Quest.

Results of Operations

  Sales and earnings growth improved during the third quarter, driven by
increasing consumer mobility compared to the prior year which experienced
COVID-19 movement restrictions. As consumer foot traffic within brick and mortar
retailers improved, particularly in the mass and convenience store channels, our
business, particularly bars, did well. Strong sales growth, cost controls around
general and administrative costs, and Acquisition of Quest synergies more than
offset higher marketing and employee-related costs.

  In assessing the performance of our business, we consider a number of key
performance indicators used by management and typically used by our competitors,
including the non-GAAP measures EBITDA and Adjusted EBITDA. Because not all
companies use identical calculations, the presentation of Adjusted EBITDA may
not be comparable to other similarly titled measures of other companies. See
"Reconciliation of EBITDA and Adjusted EBITDA" below for a reconciliation of net
income to EBITDA and Adjusted EBITDA for each applicable period.

                                       26
--------------------------------------------------------------------------------
Table of Contents
Comparison of Unaudited Results for the Thirteen Weeks Ended May 29, 2021 and
the Thirteen Weeks Ended May 30, 2020

  The following unaudited table presents, for the periods indicated, selected
information from our Condensed Consolidated Statements of Operations and
Comprehensive Income, including information presented as a percentage of net
sales:
                                    Thirteen Weeks                        Thirteen Weeks
                                        Ended                                 Ended
(In thousands)                       May 29, 2021        % of Sales        May 30, 2020        % of Sales
Net sales                         $        284,001          100.0  %    $        215,101          100.0  %
Cost of goods sold                         162,998           57.4  %             126,475           58.8  %
Gross profit                               121,003           42.6  %              88,626           41.2  %

Operating expenses:
Selling and marketing                       30,826           10.9  %              24,510           11.4  %
General and administrative                  25,668            9.0  %              28,713           13.3  %
Depreciation and amortization                4,187            1.5  %               4,248            2.0  %
Business transaction costs                       -              -  %                  47              -  %

Total operating expenses                    60,681           21.4  %              57,518           26.7  %

Income from operations                      60,322           21.2  %              31,108           14.5  %

Other income (expense):
Interest income                                  1              -  %                  29              -  %
Interest expense                            (7,985)          (2.8) %              (8,324)          (3.9) %
(Loss) gain in fair value
change of warrant liability                (35,833)         (12.6) %              31,703           14.7  %
Gain on legal settlement                     5,000            1.8  %                   -              -  %
Loss on foreign currency
transactions                                  (272)          (0.1) %                (418)          (0.2) %
Other income                                    70              -  %                  59              -  %
Total other (expense) income               (39,019)         (13.7) %              23,049           10.7  %

Income before income taxes                  21,303            7.5  %              54,157           25.2  %
Income tax expense                          15,408            5.4  %               6,045            2.8  %
Net income                        $          5,895            2.1  %    $         48,112           22.4  %

Other financial data:
Adjusted EBITDA (1)               $         67,459           23.8  %    $         43,363           20.2  %

(1) Adjusted EBITDA is a non-GAAP financial metric. See "Reconciliation of EBITDA and Adjusted EBITDA" below for a reconciliation of net income to EBITDA and Adjusted EBITDA for each applicable period.



  Net sales. Net sales of $284.0 million represented an increase of $68.9
million, or 32.0%, for the thirteen weeks ended May 29, 2021 compared to the
thirteen weeks ended May 30, 2020. The increase was primarily driven by Quest
brand net sales growth and solid e-commerce growth across both the Atkins brand
and Quest brand. The increase was partially offset by a 0.9% decrease in net
sales due to the SimplyProtein Sale and the restructuring-related business
activities in Europe in fiscal year 2021. Additionally, net sales in the
thirteen weeks ended May 29, 2021 were negatively affected by higher trade
promotions.

Cost of goods sold. Cost of goods sold increased $36.5 million, or 28.9%, for the thirteen weeks ended May 29, 2021 compared to the thirteen weeks ended May 30, 2020. The cost of goods sold increase was driven by sales volume growth.



  Gross profit. Gross profit increased $32.4 million, or 36.5%, for the thirteen
weeks ended May 29, 2021 compared to the thirteen weeks ended May 30, 2020.
Gross profit of $121.0 million, or 42.6% of net sales, for the thirteen weeks
ended May 29, 2021 increased 140 basis points from 41.2% of net sales for the
thirteen weeks ended May 30, 2020. The increase in gross profit margin was
primarily the result of favorable product form and retail channel mix given
higher shopper traffic in brick and mortar channels.

                                       27

--------------------------------------------------------------------------------

Table of Contents

Operating expenses. Operating expenses increased $3.2 million, or 5.5%, for the thirteen weeks ended May 29, 2021 compared to the thirteen weeks ended May 30, 2020 due to the following:



•Selling and marketing. Selling and marketing expenses increased $6.3 million,
or 25.8%, for the thirteen weeks ended May 29, 2021 compared to the thirteen
weeks ended May 30, 2020. The increase was primarily related to higher marketing
spend that was reinstated following a decline in the prior year period due to
the impact of COVID 19.

•General and administrative. General and administrative expenses decreased $3.0
million, or 10.6%, for the thirteen weeks ended May 29, 2021 compared to the
thirteen weeks ended May 30, 2020. The decrease was primarily attributable to a
$3.9 million reduction in costs related to the integration of Quest and a
decrease in restructuring charges of $1.2 million in the thirteen weeks ended
May 29, 2021. These decreases were partially offset by an increase in incentive
compensation in the thirteen weeks ended May 29, 2021.

•Depreciation and amortization. Depreciation and amortization expenses remained
approximately flat at $4.2 million for the thirteen weeks ended May 29, 2021 and
May 30, 2020.

•Business transaction costs. Business transaction costs were nominal for the thirteen weeks ended May 30, 2020 and comprised expenses related to the Acquisition of Quest.

Interest income. Interest income was nominal for each of the thirteen weeks ended May 29, 2021 and May 30, 2020.



  Interest expense. Interest expense decreased $0.3 million for the thirteen
weeks ended May 29, 2021 compared to the thirteen weeks ended May 30, 2020,
primarily due to principal payments reducing the outstanding balance of the Term
Facility (as defined below) to $506.5 million as of May 29, 2021 from $635.5
million as of May 30, 2020, offset by accelerated deferred financing fee
amortization.

(Loss) gain in fair value change of warrant liability. A non-cash loss of $35.8
million in fair value change of warrant liability was recorded for the thirteen
weeks ended May 29, 2021 compared to a non-cash gain of $31.7 million for the
thirteen weeks ended May 30, 2020. The increase in loss relates to changes in
the valuation of warrant liabilities primarily driven by changes in stock price
and volatility.

Gain on legal settlement. The Company recorded a $5.0 million gain on a legal settlement during the thirteen weeks ended May 29, 2021.



  Loss on foreign currency transactions. A loss of $0.3 million in foreign
currency transactions was recorded for the thirteen weeks ended May 29, 2021
compared to a foreign currency loss of $0.4 million for the thirteen weeks ended
May 30, 2020. The change relates to changes in foreign currency rates related to
international operations.

  Income tax expense. Income tax expense increased $9.4 million for the thirteen
weeks ended May 29, 2021 compared to the thirteen weeks ended May 30, 2020. The
increase in our income tax expense is primarily driven by higher income from
operations, partially offset by permanent differences.

  Net income. Net income was $5.9 million for the thirteen weeks ended May 29,
2021, a decrease of $42.2 million compared to net income of $48.1 million for
the thirteen weeks ended May 30, 2020. The decrease was primarily related to an
increase in loss in fair value change of the warrant liability.

  Adjusted EBITDA. Adjusted EBITDA increased $24.1 million, or 55.6% for the
thirteen weeks ended May 29, 2021 compared to the thirteen weeks ended May 30,
2020. For a reconciliation of Adjusted EBITDA to its most directly comparable
GAAP measure, see "Reconciliation of EBITDA and Adjusted EBITDA" below.

                                       28
--------------------------------------------------------------------------------

Comparison of Unaudited Results for the Thirty-Nine Weeks Ended May 29, 2021 and the Thirty-Nine Weeks Ended May 30, 2020



  The following unaudited table presents, for the periods indicated, selected
information from our Condensed Consolidated Statements of Operations and
Comprehensive Income, including information presented as a percentage of net
sales:
                                Thirty-Nine Weeks                      Thirty-Nine Weeks
                                      Ended                                  Ended
(In thousands)                    May 29, 2021         % of Sales        May 30, 2020         % of Sales
Net sales                      $         745,760          100.0  %    $         594,355          100.0  %
Cost of goods sold                       440,451           59.1  %              358,129           60.3  %
Gross profit                             305,309           40.9  %              236,226           39.7  %

Operating expenses:
Selling and marketing                     82,171           11.0  %               69,985           11.8  %
General and administrative                77,645           10.4  %               74,961           12.6  %
Depreciation and
amortization                              12,643            1.7  %               10,988            1.8  %
Business transaction costs                     -              -  %               26,900            4.5  %

Total operating expenses                 172,459           23.1  %              182,834           30.8  %

Income from operations                   132,850           17.8  %               53,392            9.0  %

Other income (expense):
Interest income                                4              -  %                1,493            0.3  %
Interest expense                         (24,352)          (3.3) %              (23,882)          (4.0) %
(Loss) gain in fair value
change of warrant liability              (60,714)          (8.1) %               82,655           13.9  %

Gain on legal settlement                   5,000            0.7  %                    -              -  %
Gain (loss) on foreign
currency transactions                        712            0.1  %                 (596)          (0.1) %
Other income                                 229              -  %                  104              -  %
Total other (expense)
income                                   (79,121)         (10.6) %               59,774           10.1  %

Income before income taxes                53,729            7.2  %              113,166           19.0  %
Income tax expense                        31,095            4.2  %                8,238            1.4  %
Net income                     $          22,634            3.0  %    $         104,928           17.7  %

Other financial data:
Adjusted EBITDA (1)            $         158,800           21.3  %    $         116,889           19.7  %

(1) Adjusted EBITDA is a non-GAAP financial metric. See "Reconciliation of EBITDA and Adjusted EBITDA" below for a reconciliation of net income to EBITDA and Adjusted EBITDA for each applicable period.



  Net sales. Net sales of $745.8 million represented an increase of $151.4
million, or 25.5%, for the thirty-nine weeks ended May 29, 2021 compared to the
thirty-nine weeks ended May 30, 2020. The increase was primarily attributable to
the Quest brand, which increased net sales by 22.8%, due to Quest's partial
inclusion in our results of operations in fiscal year 2020 as compared to fiscal
year 2021 as well as post-acquisition Quest brand sales volume growth. These
increases in net sales were partially offset by decreased sales volume of
approximately 1.2% related to the SimplyProtein Sale and the
restructuring-related business activities in Europe in fiscal year 2021.

  Cost of goods sold. Cost of goods sold increased $82.3 million, or 23.0%, for
the thirty-nine weeks ended May 29, 2021 compared to the thirty-nine weeks ended
May 30, 2020. The cost of goods sold increase was driven by sales volume growth
primarily attributable to the Quest brand as discussed above, which was
partially offset by the effect of the $7.5 million non-cash inventory step-up
related to the Acquisition of Quest recorded in fiscal year 2020.

                                       29
--------------------------------------------------------------------------------

  Gross profit. Gross profit increased $69.1 million, or 29.2%, for the
thirty-nine weeks ended May 29, 2021 compared to the thirty-nine weeks ended
May 30, 2020. Gross profit of $305.3 million, or 40.9% of net sales, for the
thirty-nine weeks ended May 29, 2021 increased 120 basis points from 39.7% of
net sales for the thirty-nine weeks ended May 30, 2020. The increase in gross
margin was primarily the result of the $7.5 million non-cash inventory step-up
related to the Acquisition of Quest in fiscal year 2020.

  Operating expenses. Operating expenses decreased $10.4 million, or 5.7%, for
the thirty-nine weeks ended May 29, 2021 compared to the thirty-nine weeks ended
May 30, 2020 due to the following:

•Selling and marketing. Selling and marketing expenses increased $12.2 million,
or 17.4%, for the thirty-nine weeks ended May 29, 2021 compared to the
thirty-nine weeks ended May 30, 2020. The increase was primarily related to
Quest's partial inclusion in our results of operations in fiscal year 2020 as
compared to fiscal year 2021, which was partially offset by decreased selling
and marketing expenses related to the SimplyProtein Sale and the
restructuring-related business activities in Europe.

•General and administrative. General and administrative expenses increased $2.7
million, or 3.6%, for the thirty-nine weeks ended May 29, 2021 compared to the
thirty-nine weeks ended May 30, 2020. The increase was primarily attributable to
Quest's partial inclusion in our results of operations in fiscal year 2020 as
compared to fiscal year 2021 as well as restructuring charges of $4.0 million in
fiscal year 2021. These increases were partially offset by the reductions in
costs related to the integration of Quest and stock-based compensation.

•Depreciation and amortization. Depreciation and amortization expenses increased
$1.7 million, or 15.1%, for the thirty-nine weeks ended May 29, 2021 compared to
the thirty-nine weeks ended May 30, 2020. The increase was primarily due to the
partial inclusion of amortization expense related to intangible assets
recognized as part of the Acquisition of Quest in fiscal year 2020 as compared
to fiscal year 2021.

•Business transaction costs. Business transaction costs were $26.9 million for
the thirty-nine weeks ended May 30, 2020 and comprised expenses related to the
Acquisition of Quest.

  Interest income. Interest income decreased $1.5 million for the thirty-nine
weeks ended May 29, 2021 compared to the thirty-nine weeks ended May 30, 2020,
primarily due to $195.3 million of cash on hand being utilized for the
Acquisition of Quest in the first quarter of fiscal year 2020 and lower market
rates.

  Interest expense. Interest expense increased $0.5 million for the thirty-nine
weeks ended May 29, 2021 compared to the thirty-nine weeks ended May 30, 2020,
primarily due to the funding of the Term Facility in the amount of $460.0
million to partially finance the Acquisition of Quest in the first quarter of
fiscal 2020.

(Loss) gain in fair value change of warrant liability. A non-cash loss of $60.7
million in fair value change of warrant liability was recorded for the
thirty-nine weeks ended May 29, 2021 compared to a non-cash gain of $82.7
million for the thirty-nine weeks ended May 30, 2020. The loss relates to
changes in the valuation of warrant liabilities, primarily driven by changes in
stock price and volatility.

Gain on legal settlement. The Company recorded a $5.0 million gain on a legal settlement during the thirty-nine weeks ended May 29, 2021.

Gain (loss) on foreign currency transactions. A gain of $0.7 million in foreign currency transactions was recorded for the thirty-nine weeks ended May 29, 2021 compared to a foreign currency loss of $0.6 million for the thirty-nine weeks ended May 30, 2020. The change relates to changes in foreign currency rates related to international operations.

Income tax expense. Income tax expense increased $22.9 million for the thirty-nine weeks ended May 29, 2021 compared to the thirty-nine weeks ended May 30, 2020. The increase in our income tax expense is primarily driven by higher income from operations, partially offset by permanent differences.

Net income. Net income was $22.6 million for the thirty-nine weeks ended May 29, 2021 a decrease of $82.3 million compared to net income of $104.9 million for the thirty-nine weeks ended May 30, 2020. The decrease was primarily related to an increase in loss in fair value change of the warrant liability.



  Adjusted EBITDA. Adjusted EBITDA increased $41.9 million, or 35.9% for the
thirty-nine weeks ended May 29, 2021 compared to the thirty-nine weeks ended
May 30, 2020, driven primarily by the Acquisition of Quest. For a reconciliation
of Adjusted EBITDA to its most directly comparable GAAP measure, see
"Reconciliation of EBITDA and Adjusted EBITDA" below.

                                       30
--------------------------------------------------------------------------------

Reconciliation of EBITDA and Adjusted EBITDA



  EBITDA and Adjusted EBITDA are non-GAAP financial measures commonly used in
our industry and should not be construed as alternatives to net income as an
indicator of operating performance or as alternatives to cash flow provided by
operating activities as a measure of liquidity (each as determined in accordance
with GAAP). Simply Good Foods defines EBITDA as net income or loss before
interest income, interest expense, income tax expense, depreciation and
amortization, and Adjusted EBITDA as further adjusted to exclude the following
items: business transaction costs, stock-based compensation expense, inventory
step-up, integration costs, restructuring costs, non-core legal costs, gain or
loss in fair value change of warrant liability, gain or loss due to legal
settlements, and other non-core expenses. The Company believes that EBITDA and
Adjusted EBITDA, when used in conjunction with net income, are useful to provide
additional information to investors. Management of the Company uses EBITDA and
Adjusted EBITDA to supplement net income because these measures reflect
operating results of the on-going operations, eliminate items that are not
directly attributable to the Company's underlying operating performance, enhance
the overall understanding of past financial performance and future prospects,
and allow for greater transparency with respect to the key metrics the Company's
management uses in its financial and operational decision making. The Company
also believes that Adjusted EBITDA is frequently used by securities analysts,
investors and other interested parties in the evaluation of companies in its
industry. Adjusted EBITDA may not be comparable to other similarly titled
captions of other companies due to differences in the non-GAAP calculation.

  The following unaudited tables below provide a reconciliation of EBITDA and
Adjusted EBITDA to their most directly comparable GAAP measure, which is net
income, for the thirteen and thirty-nine weeks ended May 29, 2021 and May 30,
2020:
                                  Thirteen Weeks Ended                    Thirty-Nine Weeks Ended
 (In thousands)             May 29, 2021        May 30, 2020          May

29, 2021 May 30, 2020


 Net income               $     5,895          $      48,112      $      22,634           $     104,928
 Interest income                   (1)                   (29)                (4)                 (1,493)
 Interest expense               7,985                  8,324             24,352                  23,882
 Income tax expense            15,408                  6,045             31,095                   8,238
 Depreciation and
 amortization                   4,487                  4,488             13,508                  11,607
 EBITDA                        33,774                 66,940             91,585                 147,162
 Business transaction
 costs                              -                     47                  -                  26,900
 Stock-based
 compensation expense           2,172                  2,150              5,766                   5,945
 Inventory step-up                  -                      -                  -                   7,522
 Integration of Quest             244                  4,094              2,458                   9,435
 Restructuring                    206                  1,386              3,992                   1,386
 Non-core legal costs               -                     48                  -                     603
 Loss (gain) in fair
 value change of
 warrant liability             35,833                (31,703)           

60,714                 (82,655)
 Gain on legal
 settlement                    (5,000)                     -             (5,000)                      -
 Other (1)                        230                    401               (715)                    591

Adjusted EBITDA $ 67,459 $ 43,363 $ 158,800

$     116,889

(1) Other items consist principally of exchange impact of foreign currency transactions and other expenses.


                                       31
--------------------------------------------------------------------------------

Liquidity and Capital Resources

Overview



  We have historically funded our operations with cash flow from operations and,
when needed, with borrowings under our credit facilities. Our principal uses of
cash have been debt service, working capital and the Acquisition of Quest.

  We had $90.2 million in cash and cash equivalents as of May 29, 2021. We
believe our sources of liquidity and capital will be sufficient to finance our
continued operations, growth strategy and additional expenses we expect to incur
for at least the next twelve months. As circumstances warrant, we may issue debt
and/or equity securities from time to time on an opportunistic basis, dependent
upon market conditions and available pricing. We make no assurance that we can
issue and sell such securities on acceptable terms or at all.

Debt and Credit Facilities



  On July 7, 2017, we entered into a credit agreement with Barclays Bank PLC and
other parties (as amended to date, the "Credit Agreement"). The Credit Agreement
provides for (i) a term facility of $200.0 million ("Term Facility") with a
seven-year maturity and (ii) a revolving credit facility of up to $75.0 million
(the "Revolving Credit Facility") with a five-year maturity. Substantially
concurrent with the consummation of the Acquisition of Atkins, the full $200.0
million of the Term Facility (the "Term Loan") was drawn. The interest rate per
annum is based on either (i) a base rate equaling the higher of (a) the "prime
rate", (b) the federal funds effective rate plus 0.50% or (c) the Euro-currency
rate applicable for an interest period of one month plus 1.00% plus (x) 3.00%
margin for the Term Loan or (y) 2.00% margin for the Revolving Credit Facility,
or (ii) London Interbank Offered Rate ("LIBOR") adjusted for statutory reserve
requirements, plus (x) 4.00% margin for the Term Loan subject to a floor of
1.00% or (y) 3.00% margin for the Revolving Credit Facility. As security for the
payment or performance of its debt, we have pledged certain equity interests in
its subsidiaries.

  On March 16, 2018 (the "Amendment Date"), we entered into an amendment (the
"Repricing Amendment") to the Credit Agreement. As a result of the Repricing
Amendment, the interest rate on the Term Loan was reduced and, as of the
Amendment Date, such loans had an interest rate equal to, at our option, either
LIBOR plus an applicable margin of 3.50% or a base rate plus an applicable
margin of 2.50%. The Repricing Amendment did not change the interest rate on the
Revolving Credit Facility. The Revolving Credit Facility continued to bear
interest based upon our consolidated net leverage ratio as of the last financial
statements delivered to the administrative agent. No additional debt was
incurred, or any proceeds received, by us in connection with the Repricing
Amendment. The incremental fees paid to the administrative agent are reflected
as additional debt discount and are amortized over the terms of the long-term
financing agreements using the effective-interest method.

  On November 7, 2019, we entered into an amendment (the "Incremental Facility
Amendment") to the Credit Agreement to increase the principal borrowed on the
Term Facility by $460.0 million. The Term Facility together with the incremental
borrowing make up the Initial Term Loans (as defined in the Incremental Facility
Amendment) and as of the Amendment No. 2 Effective Date (as defined in the
Incremental Facility Amendment), the Initial Term Loans bear interest at a rate
equal to, at our option, either LIBOR plus an applicable margin of 3.75% or a
base rate plus an applicable margin of 2.75%. The Incremental Facility Amendment
was executed to partially finance the Acquisition of Quest. No amounts under the
Term Facility were repaid as a result of the execution of the Incremental
Facility Amendment.

  The Applicable Rate per annum applicable to the loans under the Credit
Agreement Amendment is, with respect to any Initial Term Loan that is an ABR
Loan (as defined in the Credit Agreement), 2.75% per annum, and with respect to
any Initial Term Loan that is a Eurodollar Loan, 3.75% per annum. The
incremental term loans will mature on the maturity date applicable to the
Initial Term Loans, which is July 7, 2024.

  The Credit Agreement contains certain financial and other covenants that limit
our ability to, among other things, incur and/or undertake asset sales and other
dispositions, liens, indebtedness, certain acquisitions and investments,
consolidations, mergers, reorganizations and other fundamental changes, payment
of dividends and other distributions to equity and warrant holders, and
prepayments of material subordinated debt, in each case, subject to customary
exceptions materially consistent with credit facilities of such type and size.
The Revolving Credit Facility has a maximum total net leverage ratio equal to or
less than 6.25:1.00 (with a reduction to 6.00:1.00 on and after the third
anniversary of the closing date of the Credit Agreement) contingent on credit
extensions in excess of 30% of the total amount of commitments available under
the Revolving Credit Facility. Any failure to comply with the restrictions of
the credit facilities may result in an event of default. We were in compliance
with all financial covenants as of May 29, 2021 and August 29, 2020,
respectively.

  At May 29, 2021, the outstanding balance of the Term Facility was $506.5
million. We are not required to make principal payments on the Term Facility
over the twelve months following the period ended May 29, 2021. The outstanding
balance of the Term Facility is due upon its maturity in July 2024. As of
May 29, 2021, there were no amounts drawn against the Revolving Credit Facility.

                                       32
--------------------------------------------------------------------------------

Public Equity Offering



  On October 9, 2019, we completed an underwritten public offering of 13,379,205
shares of our common stock at a price to the public of $26.35 per share. We paid
underwriting discounts and commissions of $0.19 per share resulting in net
proceeds to us of $26.16 per share, or approximately $350.0 million (the
"Offering"). We paid $0.8 million for legal, accounting and registrations fees
related to the Offering. The net proceeds were used to pay a portion of the
purchase price and related fees and expenses for the Acquisition of Quest.

Acquisition of Quest



  On August 21, 2019, our wholly-owned subsidiary Simply Good Foods USA, Inc.,
formerly known as Atkins Nutritionals, Inc. ("Simply Good USA") entered into a
Stock and Unit Purchase Agreement with VMG Voyage Holdings, LLC, VMG Tax-Exempt
II, L.P., Voyage Employee Holdings, LLC, and other sellers, as defined in the
Purchase Agreement, to acquire Quest, a healthy lifestyle food company. On
November 7, 2019, pursuant to the Purchase Agreement, Simply Good USA completed
the Acquisition of Quest, for a cash purchase price of approximately $1.0
billion, subject to customary post-closing adjustments.

  The Acquisition of Quest was funded through a combination of cash, equity and
debt financing. Total consideration paid on the closing date was $988.9 million.
Cash sources of funding included $195.3 million of cash on hand, net proceeds of
approximately $350.0 million from an underwritten public offering of common
stock, and $443.6 million in new term loan debt. In the third fiscal quarter of
2020, we received a post-closing release from escrow of approximately $2.1
million related to net working capital adjustments, resulting in a total net
consideration paid of $986.8 million. For the thirteen and thirty-nine weeks
ended May 30, 2020, we incurred no business transaction costs and $26.9 million
of business transaction costs, respectively.

Private Warrants to Purchase Common Stock



  The Company's private placement warrants to purchase 6,700,000 shares of the
common stock remain outstanding, are held by Conyers Park Sponsor, LLC, a
related party, and remain liability-classified. If all Private Warrants are
exercised at the $11.50 exercise price per warrant, our cash would increase by
$77.1 million.

Cash Flows

The following table sets forth the major sources and uses of cash for each of the periods set forth below (in thousands):



                                                                Thirty-Nine 

Weeks Ended


                                                            May 29, 2021        May 30, 2020
Net cash provided by operating activities                $     91,488          $      24,100
Net cash provided by (used in) investing activities      $      2,454          $    (984,306)
Net cash (used in) provided by financing activities      $    (99,889)         $     805,586



  Operating activities. Our net cash provided by operating activities increased
$67.4 million to $91.5 million for the thirty-nine weeks ended May 29, 2021
compared to cash provided by operating activities of $24.1 million for the
thirty-nine weeks ended May 30, 2020. The increase in cash provided by operating
activities was primarily attributable to higher operating income driven by (i)
the Quest® brand sales volume growth, which increased net sales by 22.8% due to
Quest's partial inclusion in our results of operations in fiscal year 2020 as
compared to fiscal year 2021, as well as post-acquisition Quest brand sales
volume growth and (ii) significant reductions in cash outlays and changes in
working capital related to the first quarter 2020 Acquisition of Quest,
including decreases in business transaction costs of $26.9 million and
integration costs of $7.0 million. These increases were partially offset by $6.9
million of cash payments made for restructuring-related costs, predominately
composed of termination benefits and severance payments, during the thirty-nine
weeks ended May 29, 2021. Additionally, cash paid for taxes increased $10.6
million for the thirty-nine weeks ended May 29, 2021 compared to the thirty-nine
weeks ended May 30, 2020.

  Investing activities. Our net cash provided by investing activities was $2.5
million for the thirty-nine weeks ended May 29, 2021, which was primarily
related to the $5.8 million of cash proceeds received from the SimplyProtein
Sale, partially offset by purchases of property and equipment of $3.2 million.
The net cash used in investing activities of $984.3 million for the thirty-nine
weeks ended May 30, 2020 was primarily related to the cash paid for the
Acquisition of Quest, net of cash acquired, of $982.1 million.

  Financing activities. Our net cash used in financing activities was $99.9
million for the thirty-nine weeks ended May 29, 2021 compared to net cash
provided by financing activities of $805.6 million for the thirty-nine weeks
ended May 30, 2020. Net cash used in financing activities for the thirty-nine
weeks ended May 29, 2021 primarily consisted of $100.0 million in principal
payments on the Term Facility. For the thirty-nine weeks ended May 30, 2020, net
cash provided by financing activities included gross proceeds of $352.5 million
from the Offering partially offset by issuance costs of $3.3 million, proceeds
of $460.0 million from the Term Facility
                                       33
--------------------------------------------------------------------------------
Table of Contents
borrowing related to the Incremental Facility Amendment partially offset by
issuance costs of $8.2 million, and a $21.0 million principal payment on the
Term Facility.

Contractual Obligations

Our contractual obligations are related to our Credit Agreement and our finance and operating leases. There have been no material changes to our contractual obligations from our Annual Report.

Off-Balance Sheet Arrangements



  As of May 29, 2021, we had no material off-balance sheet arrangements that
have or are reasonably likely to have a current or future material effect on our
financial condition, changes in financial condition, income or expenses, results
of operations, liquidity, capital expenditures or capital resources.

New Accounting Pronouncements



  For a description of critical accounting policies that affect our significant
judgments and estimates used in the preparation of our consolidated financial
statements, refer to our Annual Report on Form 10-K/A. Refer to Note 2 of our
unaudited interim consolidated financial statements in this Report for further
information regarding recently issued accounting standards.

© Edgar Online, source Glimpses